Univariate Analysis
| Endpoint/Variable . | P . | Risk Ratio . |
|---|---|---|
| Freedom from progression | ||
| Lung or marrow involvement at presentation for transplantation | .001 | 4.086 |
| No. of extranodal sites at presentation for transplantation | .007 | 1.465 |
| Stage at presentation for transplantation | .008 | 1.625 |
| Status immediately before transplant | .010 | 2.055 |
| Symptoms at presentation for transplantation | .023 | 2.132 |
| Cytoreductive RT | .096 | 0.366 |
| Overall survival | ||
| Lung or marrow involvement at presentation for transplantation | .003 | 2.410 |
| Symptoms at presentation for transplantation | .010 | 2.171 |
| No. of extranodal sites at presentation for transplantation | .035 | 1.321 |
| Status immediately before transplant | .054 | 1.692 |
| No. of prior CT courses | .086 | 1.478 |
| Stage at presentation for transplantation | .083 | 1.303 |
| Event-free survival | ||
| Lung or marrow involvement at presentation for transplantation | .002 | 2.412 |
| Symptoms at presentation for transplantation | .003 | 2.257 |
| Status immediately before transplant | .037 | 1.697 |
| No. of extranodal sites at presentation for transplantation | .042 | 1.299 |
| Stage at presentation for transplantation | .065 | 1.297 |
| No. of cytoreductive regimens | .087 | 1.400 |
| Endpoint/Variable . | P . | Risk Ratio . |
|---|---|---|
| Freedom from progression | ||
| Lung or marrow involvement at presentation for transplantation | .001 | 4.086 |
| No. of extranodal sites at presentation for transplantation | .007 | 1.465 |
| Stage at presentation for transplantation | .008 | 1.625 |
| Status immediately before transplant | .010 | 2.055 |
| Symptoms at presentation for transplantation | .023 | 2.132 |
| Cytoreductive RT | .096 | 0.366 |
| Overall survival | ||
| Lung or marrow involvement at presentation for transplantation | .003 | 2.410 |
| Symptoms at presentation for transplantation | .010 | 2.171 |
| No. of extranodal sites at presentation for transplantation | .035 | 1.321 |
| Status immediately before transplant | .054 | 1.692 |
| No. of prior CT courses | .086 | 1.478 |
| Stage at presentation for transplantation | .083 | 1.303 |
| Event-free survival | ||
| Lung or marrow involvement at presentation for transplantation | .002 | 2.412 |
| Symptoms at presentation for transplantation | .003 | 2.257 |
| Status immediately before transplant | .037 | 1.697 |
| No. of extranodal sites at presentation for transplantation | .042 | 1.299 |
| Stage at presentation for transplantation | .065 | 1.297 |
| No. of cytoreductive regimens | .087 | 1.400 |